Roche Pharma AG
PolandAll medications by this manufacturer
-
Madopar
Form: capsules
Active substance Dosage levodopa 200 mg benserazide 50 mg ATC: N04BA02
-
Madopar 125 mg
Form: capsules
Active substance Dosage levodopa 100 mg benserazide 25 mg ATC: N04BA02
-
Madopar 125 mg
Form: suspension, oral, for preparation from tablets
Active substance Dosage Levodopa 100 mg Benserazide 25 mg ATC: N04BA02
-
Madopar 62.5 mg
Form: capsules
Active substance Dosage Levodopa 50 mg Benserazide hydrochloride 12.5 mg ATC: N04BA02
-
Madopar 62.5 mg
Form: suspension, oral, for preparation from tablets
Active substance Dosage levodopa 50 mg benserazide 12.5 mg ATC: N04BA02
-
Madopar hbs
Form: capsules
Active substance Dosage Levodopa 100 mg Benserazide hydrochloride 28.5 mg ATC: N04BA02
-
Pulmozyme
Form: solution for inhalation
Active substance Dosage dornase alfa 2.5 mg ATC: R05CB13